All Type of News
KPTEC runs new GMP program for pharmaceutical technicians
Korea Pharm. Tech. Education Center (KPTEC), which was set up on February, is scheduled to start its first education program for new good manufacturing practice from April 12.
Under the program, a workshop-oriented...
Kang Moon-seok named new director at Dong-A Pharm
Dong-A Pharmaceutical, Korea's No. 1 drug maker, appointed two new directors Kang Moon-seok, the chief executive of foreign wine and liquor importer Sooseok Trading and former Dong-A president Yu Chung-sik at its boar...
Pharmacists learned medication advice informations through newspapers.
Quite a number of pharmacists in the field have learned many medication advice informations for patients and other medicinal knowledges through an off-line professional journals in great deal rather than an on-lin...
Pharmaceutical firms want more hiring of clinical research associate
Domestic and foreign-invested pharmaceutical firms are beset by shortages of clinical research associate these days.
A clinical research associate is a profession defined by Good clinical practice guidelines.
Th...
Wholesaling industry stands at crossroad
The pending issue regarding the establishment of the joint drug logistic center may be finalized as the government unveiled its much-anticipated Distribution Modernization Act last month. The proposed bill has the pot...
Lilly Korea to promote Cialis for general practitioners.
Lilly Korea is now promoting Cialis, an anti-imptence drug, with a scientific conference under the title of "Cialis Freedom symposium" targeted to other general practitioners than urological specialists starting from ...
Domestic drugmakers seeking expansion of overseas market
With the domestic pharmaceutical industry facing the imminent settlement of a free trade agreement between Korea and the United States and an ongoing drug pricing policy (so-called positive list system), drug manufact...
Drug industry to face high risk of a drug product liability act.
It is said that the drug business is extremely risk vulnerable to the product liability act in view of its double edge with the drug efficacies and adverse reactions.
.
In fact Bayer has encountered with the most ...
Patients with kidney cancer to pay only 10% of Nexava NHI price.
The NHI reimbursement of Nexava, a new oral anti-kidney cancer drug (sorafenib) and first in its kind in the world, has been approved by the MOHW. Now, the patient may pay only 10% of the drug charges under the NHI co...
Compulsory recall system to be released by 3 grades
Pharmaceutical manufacturers or importers will be obliged to disclose the list of substandard drugs to be recalled by three grades when these are found to be life-threatening or harmful, the Ministry of Health and Wel...
